FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV
Nirsevimab is the first shot approved by the FDA to protect all infants against RSV regardless of whether they are healthy or have a medical condition.
![](https://kbin.cafe/media/cache/resolve/entry_thumb/f8/b7/f8b712c7f30c56f8072c163b9daa24e1f5089bb7aad10376758c89a3bec466c9.jpg)
Nirsevimab is the first shot approved by the FDA to protect all infants against RSV regardless of whether they are healthy or have a medical condition.